Biotalys N.V. | Mid-cap | Basic Materials
€4.54
2.95%
| Biotalys N.V Stock Comparison:
Biotalys N.V vs Tessenderlo Group NVBiotalys N.V vs Syneos HealthBiotalys N.V vs Azelis Group NVBiotalys N.V vs Solvay SABiotalys N.V vs Titan CementBiotalys N.V vs BEL 20 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2021

Income Metrics

Revenue 0
Operating Income -4.4M
Net Income -3.5M

Balance Sheet Metrics

Total Assets 36.7M
Total Liabilities 9.1M
Shareholders Equity 27.6M
Debt to Equity 0.33

Cash Flow Metrics

Operating Cash Flow -4.1M
Free Cash Flow -2.4M

Revenue & Profitability Trend

Biotalys N.V Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i00000
Cost of Goods Sold i-----
Gross Profit i-----
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i11.0M16.6M18.8M13.9M11.5M
Selling, General & Administrative i5.7M6.9M6.7M6.2M3.2M
Other Operating Expenses i-1.4M-1.5M-1.5M-981.0K-930.0K
Total Operating Expenses i15.2M22.0M23.9M19.1M13.7M
Operating Income i-13.5M-20.9M-22.5M-18.1M-13.3M
Operating Margin % i0.0%0.0%0.0%0.0%0.0%
Non-Operating Items
Interest Income i534.0K655.0K23.0K5.0K1.0K
Interest Expense i157.0K161.0K247.0K246.0K86.0K
Other Non-Operating Income-----
Pre-tax Income i-13.1M-20.5M-22.8M-16.9M-10.7M
Income Tax i40.0K56.0K-38.0K16.0K13.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-13.2M-20.5M-22.7M-16.9M-10.8M
Net Margin % i0.0%0.0%0.0%0.0%0.0%
Key Metrics
EBITDA i-11.2M-18.5M-20.9M-16.5M-12.3M
EPS (Basic) i-€-0.65€-0.74€-1.10€-0.36
EPS (Diluted) i-€-0.65€-0.74€-1.10€-0.36
Basic Shares Outstanding i-31587240308981751542718930020387
Diluted Shares Outstanding i-31587240308981751542718930020387

Income Statement Trend

Biotalys N.V Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i22.6M21.6M34.1M56.1M23.1M
Short-term Investments i-----
Accounts Receivable i-----
Inventory i-----
Other Current Assets522.0K490.0K746.0K279.0K76.0K
Total Current Assets i26.2M24.9M37.8M58.9M25.5M
Non-Current Assets
Property, Plant & Equipment i7.0M7.0M6.1M5.6M4.7M
Goodwill i574.0K642.0K597.0K665.0K791.0K
Intangible Assets i574.0K642.0K597.0K665.0K791.0K
Long-term Investments-----
Other Non-Current Assets157.0K3.0K2.0K-30.0K
Total Non-Current Assets i10.5M11.7M11.8M11.3M10.8M
Total Assets i36.7M36.6M49.5M70.3M36.3M
Liabilities
Current Liabilities
Accounts Payable i1.2M1.3M2.7M1.9M2.5M
Short-term Debt i1.2M1.2M1.2M1.2M888.0K
Current Portion of Long-term Debt-----
Other Current Liabilities1.0K1.0K2.0K1.0K-
Total Current Liabilities i4.8M5.5M6.0M5.2M6.1M
Non-Current Liabilities
Long-term Debt i3.7M4.8M5.3M6.0M4.3M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities-1.0K----
Total Non-Current Liabilities i4.4M5.5M5.4M6.2M4.5M
Total Liabilities i9.1M11.0M11.4M11.4M10.6M
Equity
Common Stock i5.5M46.2M44.5M82.0M62.8M
Retained Earnings i-11.7M-40.2M-19.7M-55.9M-34.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i27.6M25.6M38.1M58.9M25.6M
Key Metrics
Total Debt i4.8M6.1M6.5M7.2M5.2M
Working Capital i21.5M19.4M31.8M53.7M19.4M

Balance Sheet Composition

Biotalys N.V Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-13.5M-20.9M-22.5M-18.1M-13.3M
Depreciation & Amortization i-----
Stock-Based Compensation i658.0K1.0M1.7M511.0K550.0K
Working Capital Changes i-968.0K2.0M-1.0M-144.0K875.0K
Operating Cash Flow i-13.8M-17.7M-21.8M-17.7M-11.8M
Investing Activities
Capital Expenditures i-107.0K-312.0K-707.0K-1.3M-3.8M
Acquisitions i-----
Investment Purchases i-10.0K000-2.1M
Investment Sales i-----
Investing Cash Flow i-118.0K-311.0K-707.0K-1.3M-5.9M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i--02.8M1.2M
Debt Repayment i-1.3M-1.3M-1.2M-1.1M-1.0M
Financing Cash Flow i13.3M5.7M-997.0K51.3M15.3M
Free Cash Flow i-12.8M-18.7M-20.8M-18.1M-13.5M
Net Change in Cash i-584.0K-12.4M-23.5M32.3M-2.4M

Cash Flow Trend

Biotalys N.V Key Financial Ratios

Valuation Ratios

Forward P/E -11.12
Price to Book 6.04
Price to Sales 52.45
PEG Ratio -11.12

Profitability Ratios

Profit Margin 0.00%
Operating Margin -217.37%
Return on Equity -49.60%
Return on Assets -23.00%

Financial Health

Current Ratio 5.50
Debt to Equity 17.56
Beta 0.95

Per Share Data

EPS (TTM) €-0.40
Book Value per Share €0.74
Revenue per Share €0.10

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
btls168.5M-6.04-49.60%0.00%17.56
Tessenderlo Group NV 1.5B37.210.86-1.40%-0.99%14.34
Syneos Health 7.4B377.861.19-1.20%-1.30%45.57
Azelis Group NV 3.1B17.671.126.41%4.01%77.22
Solvay SA 2.9B20.702.4911.13%2.81%185.12
Titan Cement 2.7B13.111.5112.28%7.88%36.26

Financial data is updated regularly. All figures are in the company's reporting currency.